Does TRICARE Cover Zepbound? 2026 Coverage, Costs, and Prior Authorization Rules

The 30-second answer: find your situation

Coverage comes down to three things — your plan, your diagnosis, and your paperwork. Find your row, get your bottom line, then jump to the section that matches you.

Sources: TRICARE, Weight Loss Products; TRICARE For Life Q&A; Express Scripts/TRICARE PA form (March 12, 2026).

Does TRICARE cover Zepbound in 2026?

Yes — but only under two conditions: you’re in a covered plan (a Prime or Select plan), and your prescription clears prior authorization. TRICARE’s official position is that it generally doesn’t cover weight-loss drugs. Zepbound is the exception when a network provider prescribes it, it’s medically necessary, and the approval criteria are met. “On the formulary” is not the same as “approved for you.”

Keep two ideas separate:

• Covered drug means Zepbound can be paid for under your plan.
• Approved for you means a reviewer at Express Scripts — the company that runs TRICARE’s pharmacy benefit — said yes to your prior authorization.

You need both, and people stall because they assume the first one delivers the second. It doesn’t. Prior authorization (“PA” for short) is simply TRICARE’s check that you meet the medical rules before it pays for an expensive drug. Your provider fills out a form; Express Scripts approves or denies it.

If you’re on Prime or Select and you’ve been putting off the conversation with your doctor — consider this your green light to start it.

Which TRICARE plans cover Zepbound — and which don’t?

TRICARE Prime plans and TRICARE Select plans can cover Zepbound for weight management when the criteria are met. TRICARE For Life, “direct care only” beneficiaries, TRICARE Plus, foreign force members, and NATO/Partnership-for-Peace beneficiaries lost weight-loss drug coverage on August 31, 2025. Your plan decides whether it’s even worth submitting a PA, so start here.

Plans that can still cover Zepbound (with an approved PA)

• TRICARE Prime plans: TRICARE Prime, Prime Remote, Prime Overseas, Prime Remote Overseas, TRICARE Young Adult–Prime, and the US Family Health Plan
• TRICARE Select plans: TRICARE Select, Select Overseas, TRICARE Reserve Select, TRICARE Retired Reserve, TRICARE Young Adult–Select, and the Continued Health Care Benefit Program (CHCBP)

For these, three things must be true: a TRICARE network provider writes the prescription, the drug is medically necessary for you, and you meet the prior authorization requirements (next section).

Plans that no longer cover weight-loss drugs

As of August 31, 2025, the Defense Health Agency stopped covering weight-loss drugs for TRICARE For Life, beneficiaries only eligible for care at military hospitals and clinics (“direct care”), TRICARE Plus, foreign force members, and beneficiaries with NATO status or a Partnership for Peace Agreement.

If you’re in one of these groups, two things follow: you can’t fill weight-loss drug prescriptions at military pharmacies, and you’ll pay full price elsewhere — even if you had an approved PA before August 31. (Express Scripts mailed notice letters to affected beneficiaries on July 31, 2025.)

Sources: TRICARE, Weight Loss Products; TRICARE For Life Q&A.

What does Zepbound cost with TRICARE?

If it’s approved, active-duty members pay $0. Most other beneficiaries pay $44–$85 for a month’s supply, depending on whether the Formulary Search Tool lists Zepbound as brand-name formulary or non-formulary. Medically retired members and certain survivors pay less. Confirm Zepbound’s current tier before you bank on a number — it sets which column you’re in.

Here are TRICARE’s official pharmacy costs for 2026 and 2027:

Source: TRICARE, Pharmacy Costs (updated April 2026).

• Active-duty family members on TRICARE Prime Remote in the U.S. pay $0 for covered drugs at military pharmacies, home delivery, and network pharmacies.
• Military pharmacies generally don’t stock non-formulary drugs without medical necessity on file. For GLP-1 weight-management drugs, an on-base military hospital or clinic (MTF) may fill it if that facility offers weight-management medications — so call ahead before you assume you can pick Zepbound up on base.
• Without any coverage, Zepbound runs up to about $1,086 a month at list price depending on dose — which is exactly why getting the PA approved (or using the manufacturer’s self-pay price) is worth the effort.

What are the prior authorization requirements for Zepbound?

This is the real gatekeeper, and the 2026 form changed. Before it ever asks about your weight, the current form checks two administrative gates — who’s prescribing, and which plan you’re in. Clear those, and it moves to the medical gates: your indication, your BMI and conditions, six months of documented lifestyle effort, a step involving older weight-loss pills, and safety questions. Miss any required step and the form says “STOP — coverage not approved.”

First, two gates that have nothing to do with your weight

This is the part most pages get wrong — and it’s the part that quietly stops approvals before your case is even read.

1. Who’s prescribing. The form asks whether the prescriber is an MTF or TRICARE Network provider who has billed TRICARE for the visit used to assess you and build your treatment plan. If the answer is no, the form stops right there — before BMI, before anything clinical. (This matters a lot for telehealth. A cash-pay telehealth service that hasn’t billed TRICARE for your assessment cannot run your TRICARE PA. If you’re using telehealth, confirm the provider is a TRICARE network provider who billed TRICARE for the relevant visit.)
2. Which plan you’re in. The form routes TRICARE Prime and Select forward. Any other enrollment stops — with a note suggesting that if you’re diabetic, a diabetes drug like Trulicity, Victoza, Ozempic, or Mounjaro may be the right request instead.

The medical gates (adult, new prescription)

Indication. The form asks why you need it: weight management, moderate-to-severe sleep apnea in an adult with obesity, or “other.” “Other” stops.

BMI + conditions. You need a BMI of 30 or higher, or a BMI of 27–29 with at least one weight-related condition. The 2026 form’s condition list is broad: diabetes or impaired glucose tolerance, obstructive sleep apnea, osteoarthritis, metabolic syndrome, high cholesterol (dyslipidemia), high blood pressure, MASH (a liver condition), or established cardiovascular disease with a history of stroke, heart attack, or peripheral artery disease. Below a BMI of 27, the form stops.

Lifestyle history. Your provider must affirm — and have documented in your medical record — that you did at least 6 months of behavior change and a reduced-calorie diet, didn’t reach your goal, and will keep going. This is the step people most often did but never got documented. No documentation, no approval.

The older-pill step (where a lot of people get stuck). The form asks: Have you tried 3 months of a generic oral weight-loss pill — phentermine, benzphetamine, diethylpropion, or phendimetrazine — and failed to lose 5%? You have three ways to clear it:

1. Yes, you tried one — your provider lists the drug name, the date, and how long you took it.
2. You can’t safely take those pills — a documented contraindication (for example, a heart rhythm problem, coronary artery disease, heart failure, stroke history, or uncontrolled high blood pressure).
3. You had a bad reaction to one that Zepbound isn’t expected to cause.

If none of those three is true and documented, the form stops here. This is one of the most common preventable stops — and it’s usually fixable by documenting a contraindication or a past trial that’s already in your history.

Safety stops. The form denies coverage if you’re pregnant, if Zepbound would be used alongside another GLP-1 medication (like Ozempic, Mounjaro, Trulicity, Victoza, Soliqua, or Xultophy), or if you have a personal or family history of medullary thyroid cancer or MEN2. These aren’t paperwork problems — they’re medical decisions for your clinician.

How long approval lasts. Initial approval is good for 12 months, with annual renewal. At renewal, an adult generally needs to show a loss of at least 5% of starting body weight after fully increasing the dose. If you stopped and are restarting Zepbound, the current form routes you back through the initial approval pathway rather than the simpler renewal one — so plan for the full packet again.

Source: Express Scripts/TRICARE PA form for semaglutide (Wegovy) and tirzepatide (Zepbound Pen Injector), dated March 12, 2026. Download the current version from the TRICARE Formulary Search Tool.

The PA form stop-map (bring this to your appointment)

This is the form, decoded into plain English — every gate, what stops you, what to bring, and how to fix it.

Does Express Scripts cover Zepbound for TRICARE?

Express Scripts runs TRICARE’s pharmacy benefit, and it covers Zepbound for TRICARE Prime and Select beneficiaries when the prior authorization is approved. It’s Express Scripts that reviews your PA, sets the copay tier, and fills the prescription through home delivery or a network pharmacy. Beneficiaries who aren’t in a Prime, Select, or premium-based plan lost weight-loss drug coverage on August 31, 2025.

So “Does Express Scripts cover it?” and “Does TRICARE cover it?” are the same question — Express Scripts is just the company that processes the answer. Practically, that means: you’ll submit the PA to Express Scripts, you’ll fill through Express Scripts’ network or home delivery, and you can call Express Scripts at the number on your TRICARE pharmacy card to check your specific status.

If you want to see how this plays out across the wider pharmacy benefit, our Express Scripts Zepbound coverage guide goes deeper.

How do you actually get TRICARE to approve Zepbound?

The fastest path isn’t a persuasive letter — it’s a clean form that matches the criteria above. Confirm your plan, download the current form, gather proof for each gate, hand your provider a complete packet, and confirm where you’ll fill it. Do that, and most denials never happen.

1. Confirm your plan. Prime or Select (path exists) versus TFL/direct-care/TRICARE Plus (no path for weight loss). One minute now saves weeks later.
2. Search “Zepbound” in the TRICARE Formulary Search Tool. This confirms current coverage, shows your copay tier, and lets you download the exact PA form your provider needs. Forms change — the 2026 version is different from older ones — so always pull the live one.
3. Build the packet. Bring documentation for every gate:
   • Current BMI, plus your starting and current weight
   • Any qualifying condition (high blood pressure, high cholesterol, sleep apnea, etc.)
   • Proof of 6+ months of diet and behavior changes, in your chart
   • Your older-pill history — drug, dates, duration, result — or a documented contraindication/bad reaction
   • A current medication list (to confirm you’re not on another GLP-1)
   • Family-history screening for thyroid cancer / MEN2
4. Hand your provider this exact request:

   “Before we submit the Zepbound PA, can we make sure it includes my plan, my BMI and any qualifying condition, my six months of lifestyle changes documented in my chart, and the exact dates and result of any prior weight-loss pill — or my contraindication to those pills? I’m trying to avoid a preventable Express Scripts denial.”

5. Confirm your fill route. Approval can apply to military pharmacies, network pharmacies, and home delivery — but real-world availability depends on the drug’s formulary status and stock. Call ahead, especially for a military pharmacy.

Why does TRICARE deny Zepbound?

Most denials aren’t a mystery — they happen when the form hits a “STOP” answer. A denial is either a true plan exclusion (which a PA can’t fix) or a documentation gap (which it usually can). Knowing which one you’re facing tells you whether to resubmit or move on.

What should you do if your Zepbound PA was denied?

First, find out why — don’t blindly resubmit. Call Express Scripts and ask which specific requirement failed. Then you’ll know whether to fix the documentation, switch the request, or appeal. A blind resubmission of the same packet usually gets the same answer.

• Plan-category denial (TFL, direct care, TRICARE Plus): A PA won’t solve this. Talk to your provider about other options and see the cash-pay section below.
• Prescriber-gate denial: Make sure your prescriber is a TRICARE network provider who billed TRICARE for your assessment, then resubmit.
• Missing-documentation denial: Ask Express Scripts which question failed, get the missing item in writing if you can, fix it, then resubmit.
• Step-therapy denial: Confirm your prior pill’s name, dates, and result — or have your provider document a contraindication or bad reaction. Don’t invent history; let your clinician handle it.
• Safety-stop denial (pregnancy, another GLP-1, thyroid history): This is a clinical decision. Don’t try to work around it.

You can also use TRICARE’s formal appeal process if you believe a denial was wrong. Express Scripts can tell you the appeal steps and deadlines for your situation.

Does TRICARE For Life cover Zepbound?

What changed on August 31, 2025?

TRICARE began applying revised criteria and ended weight-loss drug coverage for TFL, direct-care-only, TRICARE Plus, and foreign-force beneficiaries. If that’s you, weight-loss prescriptions can’t be filled at military pharmacies, and you’ll pay full price elsewhere.

“But I had an approved PA already.”

It no longer applies. TRICARE has said prior authorizations for obesity medications became invalid for these groups on August 31, 2025. (If you’re affected, don’t stop your medication abruptly — ask your provider what’s appropriate during the transition.)

What about sleep apnea or heart disease on TFL?

This is where TFL differs from Medicare. Medicare Part D may cover certain weight-loss medications for non-obesity conditions like sleep apnea or cardiovascular risk. TFL follows separate federal laws that exclude medications intended to control or reduce weight — regardless of any co-morbid condition. So if you have TFL and OSA, treat the public answer as no, and contact Express Scripts only to confirm your individual record.

The one exception worth checking: diabetes

This change is about weight-loss drugs. TRICARE still covers certain GLP-1 drugs — Ozempic, Mounjaro, Trulicity, and Victoza — to treat type 2 diabetes for all eligible patients (with PA), regardless of plan. That’s a different drug for a different diagnosis; Zepbound itself isn’t approved for diabetes on the TRICARE form. If you already have type 2 diabetes, ask your provider whether one of those fits — don’t try to reframe a weight-loss request as a diabetes one. (For how Medicare interacts with TFL here, see our Medicare and Zepbound guide.)

Source: TRICARE For Life Q&A; TRICARE, Weight Loss Products.

Does TRICARE cover Zepbound for sleep apnea?

For Prime and Select plans, yes — the 2026 form has a dedicated sleep-apnea pathway, and it’s Zepbound-specific. Zepbound became the first FDA-approved drug for moderate-to-severe obstructive sleep apnea (OSA) in adults with obesity in December 2024, and TRICARE’s current form mirrors that. Wegovy doesn’t qualify on the OSA path — only Zepbound does.

Here’s what the verified 2026 form requires for the OSA route:

• Age 18 or older
• Moderate-to-severe OSA, documented by an apnea-hypopnea index (AHI) of at least 15 events per hour (AHI is how many times an hour your breathing stops or gets shallow during sleep)
• A BMI of 30 or higher
• 6 months of provider-documented behavior change and reduced-calorie diet
• At renewal, improvement in your OSA based on a better AHI

If you’re applying through sleep apnea, the must-haves are your sleep study and AHI score, your BMI, and your lifestyle documentation. The stronger your sleep record, the cleaner the review.

Sources: FDA; Eli Lilly; Express Scripts/TRICARE PA form (March 12, 2026).

Does TRICARE cover Zepbound for diabetes — or should you ask for Mounjaro or Ozempic?

No. Zepbound’s TRICARE prior authorization form explicitly excludes diabetes as an indication. If your prescriber submits Zepbound with a diabetes diagnosis, the form stops at the indication gate.

The good news: TRICARE still covers GLP-1 drugs specifically approved for type 2 diabetes, including Ozempic (semaglutide), Mounjaro (tirzepatide), Trulicity (dulaglutide), and Victoza (liraglutide) — all with prior authorization, and for all eligible plan types. If you have type 2 diabetes, ask your provider whether one of these fits your situation. Don’t try to reframe a weight-loss request as a diabetes one; let your clinician make the indication call.

If the answer to those options is no, you’re looking at cash-pay — which is covered next.

What if TRICARE won’t cover Zepbound? Your cash-pay options

If your plan is excluded (like TFL) or you can’t clear the PA, your most direct option is buying Zepbound straight from the maker. Through Eli Lilly’s own pharmacy, LillyDirect, eligible self-pay patients can get Zepbound for $299–$449 a month depending on dose and timing — a fraction of the ~$1,086 pharmacy list price. Telehealth services are a second route, but they add a fee on top.

Here’s the honest landscape, most direct (and cheapest) first.

1) LillyDirect — the manufacturer’s self-pay route

With a valid prescription, Lilly’s Zepbound Self Pay Journey Program prices a 28-day supply of single-dose vials (or KwikPen) like this:

The trade-offs: the $449 price for the higher doses is an offer tied to refilling within 45 days of your last shipment — miss the window and you pay the regular price for that fill. You can’t bill insurance through LillyDirect, taxes and fees may apply, and Lilly can change or end the offer. Because it’s the manufacturer’s own price, this option pays us nothing — and we still list it first, on purpose.

Source: Eli Lilly / LillyDirect (pricing effective Feb. 2026).

2) Telehealth providers

Services that prescribe FDA-approved Zepbound and ship it can be convenient if you want the prescription, clinician, and delivery handled together — they typically charge a membership or visit fee on top of the medication. If you go this route, confirm each provider carries genuine, FDA-approved Zepbound and check current pricing first. We compare the legitimate ones side by side on our best Zepbound providers guide.

Disclosure: The RX Index may earn a commission from Ro links. This doesn’t change what you pay.

Your TRICARE Zepbound approval checklist

Before your provider hits “submit,” you should be able to answer every gate on the form. Print this, fill in what you can, and bring it to your appointment. It turns the official form into a packet — and packets get approved.

How we verified this guide

We built this from primary sources, then translated the legalese into plain English. Coverage decisions belong to TRICARE and Express Scripts; the prescribing decision belongs to your clinician. Our job is to make the rules clear enough that you don’t get blindsided. The RX Index is a pricing intelligence and comparison resource for GLP-1 telehealth providers.

Frequently asked questions